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Objectives. To assess the prevalence and determinants of herpes simplex virus type 2 (HSV-2) infections among pregnant women
attending mobile antenatal health clinic in rural villages in Mysore Taluk, India. Methods. Between January and September 2009,
487 women from 52 villages participated in this study. Each participant consented to provide a blood sample for HSV-2 and HIV
testing and underwent an interviewer-administered questionnaire. Results. HSV-2 prevalence was 6.7% (95% confidence interval
(CI) 4.4–9.0), and one woman tested positive for HIV.The median age of women was 20 years and 99% of women reported having
a single lifetime sex partner. Women whose sex partner traveled away from home had 2.68 (CI: 1.13–6.34) times the odds of being
HSV-2 seropositive compared to women whose sex partner did not travel. Having experienced genital lesions was also associated
with HSV-2 infection (𝑃 value = 0.08). Conclusion. The 6.7% HSV-2 prevalence was similar to results obtained in studies among
pregnant women in other parts of India. It appeared that most women in this study contracted HSV-2 from their spouses and
few regularly used condoms. This finding highlights the need for public health policies to increase awareness and education about
prevention methods among women and men living in rural India.
1. Background
An estimated 536 million people aged 15–49 are infected
with the herpes simplex virus type 2 (HSV-2) worldwide
[1]. HSV-2 is typically spread through sexual contact and
results in a lifelong infection. The predominant symptom
of the disease is genital lesions, but a majority of infected
individuals experience no symptoms or mild ones that are
often unrecognized [2]. The high rate of asymptomatic
cases enhances HSV-2 transmission because asymptomatic
individuals shed the virus and transmit the disease [3].
Pregnant women are particularly vulnerable to the
adverse sequelae of HSV-2 infection [4]. HSV-2 infection
in pregnancy has been associated with premature delivery,
low birthweight infants, fetal malformations, and vertical
transmission of the virus during childbirth [4, 5]. While
neonatal herpes occurs in less than 1% of prevalent infections,
the risk of transmission increases to 25–50% among women
infected during pregnancy [6, 7]. In addition, it is estimated
that prevalentHSV-2 infection is associatedwith a 2- to 4-fold
increased risk of HIV-1 acquisition [8].
The seroprevalence of HSV-2 varies by region, country,
and population [9]. Various studies have estimated that about
40% of pregnant women in sub-Saharan Africa, 30% in
Latin America, 17–22% in North America, and 4 to 24%
in Europe are HSV-2 infected [8, 10–12]. An analysis of
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prevalence by country shows even greater heterogeneity.
Studies from Sweden, Italy, Switzerland, and China show the
HSV-2 prevalence in antenatal cases of 10.4%, 7.6%, 20.7%,
and 10.8%, respectively [10, 13–15].
There are few studies describing HSV-2 prevalence
among pregnant women in India. One cross-sectional study
conducted among 1,640 pregnant women attending antenatal
clinics in Arunachal Pradesh, Assam, Manipur, Meghalaya,
and Mizoram (all states are located in the northeast of
India) foundoverallHSV-2 seroprevalence of 8.7%with states
ranging from a high of percentage 15% in Arunachal Pradesh
to a low percentage of 2.7% inManipur [16]. Another study of
asymptomatic pregnant females attending the Obstetrics and
Gynecology Outpatient Department for a routine antenatal
checkup in the North Indian State of Jammu found HSV-2
prevalence of 7.5% [17].
With one antenatal study from Tamil Nadu, a southern
state in India, and limited seroprevalence estimates from
other parts of the country, there is a great need for additional
studies among pregnant women [18]. The research describes
the prevalence and determinants of HSV-2 infection among
pregnant women living in rural villages in Mysore Taluk,
Karnataka, India.
2. Methods
2.1. Setting. Public Health Research Institute of India
(PHRII) is a nonprofit organization based in Mysore, India.
PHRII operates a health clinic in Mysore providing free
reproductive healthcare to women. PHRII maintains a public
health laboratory and conducts mobile health clinics offering
integrated antenatal care and HIV testing services in villages
in Mysore Taluk for pregnant women. Mysore Taluk is
located in the southern part of the state of Karnataka, India.
2.2. Study Population. Pregnant women living in rural vil-
lages located inMysore Talukwere enrolled in the study from
January to September 2009. Pregnant women in the villages
were recruited through extensive community outreach and
with the assistance of community and local health profession-
als. A total of 487 women from 52 villages submitted blood
samples to be tested for HSV-2 and HIV. The Institutional
Review Boards at the University of California, Berkeley, and
Public Health Research Institute of India approved the study
protocol.
2.3. Study Design. A list of the 141 villages in Mysore Taluk
was obtained through the 2001 Indian Census and 52 villages
were randomly selected to participate in an intervention
providing integrated antenatal care and HIV testing using
mobile medical clinics. Prior to the health camp, an outreach
team met with village leaders and local health professionals
to seek permission to work in the community. The team
also met with the national rural health mission workers—the
auxiliary nurse midwife (ANM), the accredited social health
activist (ASHA),Anganwadi teacher and helper to discuss the
program.The Anganwadi teacher provided a list of registered
pregnant women in each of the villages and assisted in refer-
ring these women to the health clinic. Mobile health clinics
were typically conducted in primary schools or community
halls located in each village one day after a community-
wide education and awareness program was conducted on
the importance of antenatal care and institutional deliveries.
Pregnant women were offered a free antenatal screening
including clinical examination and laboratory evaluation and
completed an interviewer-administered questionnaire.
2.4. Interview and Counseling. All pregnant women who
came to the mobile medical clinic were offered pretest
counseling in groups in the local language of Kannada. Each
woman was then directed to a private space where she could
discuss and ask any questions or clarifications before pro-
ceeding further through the program.Then, a trained female
interviewer used a standardized questionnaire to collect
information on sociodemographic status, work experience
and economic status, knowledge about HIV/AIDS, sexual
history, information onmain sex partners, history of sexually
transmitted infections, andHIV test reports. All womenwere
assured of confidentiality of their responses.
2.5. Diagnostic Testing. After completion of an examination
by the physician, a trained nurse collected blood samples
from consenting participants to screen for HSV-2, HIV,
and other routine antenatal investigations. Diagnostic tests
were performed in the PHRII laboratory in Mysore. A type-
specific ELISA was used to detect HSV-2 IgG antibodies in
sera (Focus Technologies, Cypress, CA, USA). Tests were
performed following manufacturer instructions using index
values > 1.1 to define positive results. A blinded panel of
20 serum samples provided by St. John’s Medical College
Research Institute, Bangalore, was used to validate testing and
results were in agreement with 20 out of 20 samples. The
first 89 samples were run in duplicate and all results were
successfully replicated. In addition, all positive test results
were duplicated to provide confirmation. HIV testing was
performed using ELISA following manufacturer instructions
(HIVASE 1 + 2, General Biologicals Corporation, Taiwan). All
HIV testing was performed in duplicate. Any woman who
was found to be infected with HIVwas providedmedications
for prevention of vertical transmission of HIV and referred to
the antiretroviral therapy center in KR Hospital. All women
were subsequently followed up after delivery up to a period
of two years.
2.6. Statistical Analysis. Data were analyzed using Stata
10.1 (Stata Corporation, College Station, TX). Pearson’s chi-
square test adjusted to account for the cluster survey design
was used to assess association of clinical characteristics and
HSV-2 status using a 𝑃 value cutoff of 0.1 for significance
[19]. To obtain odds ratios, data were modeled using logis-
tic regression, with HSV-2 status as the binary outcome
of interest. In addition, relative risks were obtained using
a generalized linear model with a log link function and
binomial distribution. A cluster survey design was used
because pregnant women were geographically grouped into
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villages; thus robust variance estimates adjustedwithin village
correlation were obtained [19].
3. Results
Most of the pregnant women in the selected villages par-
ticipated in the program. Only 21 pregnant women in the
community did not provide a blood sample, either because
they had only recently done their antenatal investigations
(𝑛 = 8) or they declined to attend the medical clinic for
personal reasons (𝑛 = 13). Of the 487 (95.6%) pregnant
women tested for HSV-2 antibodies, 32 tested positive, giving
a prevalence of 6.6%. Accounting for the cluster design of
the sampling gives a prevalence of 6.7% (95% confidence
interval (CI): 4.4–9.0). Of these 487 women, only one woman
(0.2%) tested positive for human immunodeficiency virus
antibodies.
Of the 487 women who provided a blood sample, 478
(98%) agreed to be interviewed, which included all women
who tested positive for HSV-2. Characteristics of the study
population are shown in Table 1. The median age of the study
population was 20 years, ranging from 15 to 33 years of
age. Education level varied, with 13% of women reporting
completion of less than one year of education, while 33%
had completed 1–7 years, 36% had completed 8–10 years, and
18% had completed more than 10 years of school. All but one
woman participating in the study were married, with 34% of
women married for one year or less, 40% married between
1 and 3 years, and only 26% married for longer than three
years. About half the women in the study had children (52%).
The median household income per month was 3000 INR (1
USD = 45.9 INR), ranging from 0 to 40,000 INR per month,
while only 2.7% (13/478) of participants reported regularly
earning income themselves. Almost all of the participants
(99.2%, 473/477) in the study population reported a single
sex partner in their lifetime and 88.7% (422/476) of study
participants reported never using a condom with their main
sex partner.
The majority of participants who tested positive for
HSV-2 did not report symptoms commonly associated with
HSV-2 (Table 2). Vaginal sores were experienced by 4% of
the women in the study, while 21% reported experiencing
painful urination and 13% reported having abnormal vaginal
discharge. Evidence of an association was found for the
presence of vaginal sores (𝑃 value = 0.08), with 9% of HSV-2
seropositive women reporting vaginal sores compared to 3%
of HSV-2 seronegative women. Painful urination (𝑃 value =
0.26) and abnormal vaginal discharge (𝑃 value = 0.49) were
not associated with HSV-2 status.
Using logistic regression, the unadjusted odds ratio was
determined for each characteristic (Table 3). The only char-
acteristic that showed evidence of affecting the odds of HSV-
2 infection was if the sex partner ever traveled away from
home, where participants whose partner ever traveled had
2.68 times the odds of being HSV-2 positive as compared
to participants whose partner never traveled (95% CI: 1.14–
6.34). A generalized linear model estimated the relative risk
of HSV-2 among women whose partners ever traveled to be
Table 1: Descriptive characteristics of the sample of pregnant
women attending the mobile medical clinics in rural Mysore, India.
Characteristic
HSV-2
Seronegative Seropositive
No. (%) No. (%)
Age 446 32
≤17 15 28.6% 0 0%
18–20 228 60.0% 15 46.8%
21–23 142 32.1% 11 34.4%
≥24 61 13.9% 6 18.8%
Education completed, years 445 32
None 60 13.5% 4 12.5%
1–7 144 32.4% 14 43.8%
8–10 165 37.1% 6 18.8%
>10 76 17.1% 8 15.0%
Length of marriage, years 446 32
≤1 151 33.9% 10 31.3%
1–3 181 40.6% 11 34.4%
>3 114 25.6% 11 34.4%
Have children 446 32
No 248 55.6% 19 59.4%
Yes 198 44.4% 13 40.6%
Household income, INR/month 445 32
<4000 ($87 USD) 232 52.1% 18 56.3%
≥4000 ($87 USD) 213 47.9% 14 43.8%
Sex while you or partner was under
influence of alcohol 441 32
Never 386 87.5% 26 81.3%
Ever 55 12.5% 6 18.8%
Main partner smokes cigarettes 439 32
Never 288 65.6% 23 71.9%
Ever 151 34.4% 9 28.1%
Main partner education completed,
years 443 32
None 119 26.9% 10 31.3%
1–7 115 26.0% 9 28.1%
8–10 130 29.4% 6 18.8%
>10 79 17.8% 7 21.9%
Main partner travels 444 32
Never 402 90.5% 25 78.1%
Ever 42 9.5% 7 21.9%
Main partner had other sex partners 444 32
Never 374 84.2% 25 78.1%
Ever 48 10.8% 3 9.4%
Do not know/refused 22 5.0% 4 12.5%
2.44 (95% CI: 1.16–5.14) times greater than the probability of
women whose husbands never traveled.
To control for possible confounding, multivariable logis-
tic regression was used to adjust for the participant’s age and
husband’s education level. In this model, women whose main
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Table 2: Clinical characteristics of the sample of pregnant women
living in rural Mysore Taluk, India.
Characteristics
HSV-2 Design-based
Pearson
P value
Seronegative
(n = 443)
Seropositive
(n = 32)
No. (%) No. (%)
Vaginal sores 0.077
Ever 14 3.1% 3 9.4%
Never 429 96.8% 29 90.6%
Painful urination 0.258
Ever 89 20.1% 9 28.1%
Never 354 79.9% 23 71.9%
Abnormal vaginal
discharge∗ 0.492
Ever 55 12.4% 5 15.6%
Never 387 87.6% 27 84.4%
∗One individual with missing data.
sex partner ever traveled away from home had 2.77 (95%
CI: 1.20–6.41) times the odds of having a prevalent HSV-2
infection.
4. Discussion
This study found HSV-2 prevalence of 6.7% among pregnant
women attending mobile antenatal care clinics in 52 rural
villages located in Mysore Taluk, Karnataka, India. This is
comparable to previously obtainedmeasures ofHSV-2 preva-
lence among other pregnant women in India [16, 17]. The
6.7% prevalence is lower than the three previously obtained
estimates of HSV-2 prevalence in the state of Karnataka,
which ranged from 10.9 to 18.9% [20–22] although these
studies focused on nonpregnant populations.
Almost all the women in this study reported having
a single sex partner in their lifetime and one woman
reported being unmarried. It appears that the main route
of HSV-2 transmission in this population is through sexual
transmission from their spouses. Since very few married
women consistently use a condom, the risk behavior of their
husbands is a primary risk factor.This information highlights
the need to increase awareness and discuss risk behaviors
among both men and women living in rural India.
In our exploratory analysis, only having a husband who
traveled away from homewas significantly associated with an
increased risk of HSV-2 infection. 𝑃 values were not adjusted
for multiple comparisons. Misclassification should not have
affected this finding since women would know how often
their husbands traveled and there is no social stigma attached
to this activity. In addition, living in a small rural village
may present limited opportunity for sex outside of marriage,
so only husbands who travel may have access to other sex
partners. Furthermore, this may be the main entry point for
HSV-2 into rural communities since sex workers are more
common in urban areas and have been shown to have high
rates of HSV-2 infection [23].
Table 3: Correlates of HSV-2 infection among pregnant women
living in rural Mysore Taluk, India.
Characteristic
HSV-2 seropositivity
OR 95% CI RR 95% CI
Age
15–19 1.00 1.00
20–24 1.19 (0.49, 2.89) 1.18 (0.51, 2.71)
>25 1.51 (0.49, 4.67) 1.47 (0.52, 4.16)
Education completed,
years
None 1.00 1.00
1–7 1.46 (0.45, 4.76) 1.42 (0.47, 4.27)
8–10 0.55 (0.17, 1.81) 0.56 (0.18, 1.75)
>10 1.58 (0.42, 5.95) 1.52 (0.45, 5.20)
Length of marriage,
years
<1 1.00 1.00
1–3 0.92 (0.42, 2.02) 0.92 (0.44, 1.93)
>3 1.46 (0.70, 3.04) 1.42 (0.72, 2.79)
Have children
No 1.00 1.00
Yes 0.86 (0.38, 1.96) 0.87 (0.40, 1.87)
Household income,
INR/month
<4000 1.00 1.00
>4000 0.85 (0.35, 2.04) 0.86 (0.38, 1.95)
Sex while you or partner
was under influence of
alcohol
Never 1.00 1.00
Ever 1.62 (0.67, 3.92) 1.56 (0.70, 3.48)
Main partner smokes
cigarettes
Never 1.00 1.00
Ever 0.75 (0.34, 1.64) 0.76 (0.36, 1.59)
Main partner education
completed, years
None 1.00 1.00
1–7 0.93 (0.36, 2.44) 0.94 (0.38, 2.28)
8–10 0.55 (0.19, 1.58) 0.57 (0.21, 1.54)
>10 1.05 (0.43, 2.60) 1.05 (0.46, 2.41)
Main partner travels
Never 1.00 1.00
Ever 2.68 (1.13, 6.34)∗ 2.44 (1.16, 5.14)∼
Main partner had other
sex partners
No 1.00 1.00
Yes 0.94 (0.28, 3.15) 0.94 (0.30, 2.95)
Do not know/refused 2.72 (0.89, 8.27) 2.46 (0.94, 6.43)
∗P value = 0.026.
∼P value = 0.020.
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It is possible that this study overestimated the prevalence
of HSV-2 in this population. There is a debate about the
accuracy of the Focus Diagnostics HerpeSelect HSV-2 IgG
ELISA test kits used in this study. Some researchers have
suggested that the cutoff value for a positive test should be
raised from 1.1 to 3.0 or 3.5 when the test is used in low
prevalence settings [24, 25]. Raising the cutoff value to 3.5
would have affected the study results since 14 of the 32 positive
tests fell in the disputed range, decreasing the estimated
prevalence from 6.6% to 4.7%. Additional HSV-2 studies
should be conducted using a gold standard like western blot
to confirm the results.
In this study, the majority of HSV-2 positive individuals
did not report experiencing symptoms caused byHSV-2.This
is consistent with previous findings that HSV-2 is frequently
asymptomatic or symptoms go unrecognized. We did find an
association between the presence of vaginal sores and HSV-
2 (𝑃 value = 0.08). However, only 9.4% of HSV-2 positive
women reported experiencing vaginal sores, highlighting the
challenge of diagnosing HSV-2 and the ability of HSV-2 to
circulate undetected in a population.
There are several limitations to the study. Information
about spouseswas obtained fromparticipantswhowere likely
to possess incomplete knowledge of their partners’ behaviors,
resulting in misclassification.There is the possibility of social
desirability bias. Though interviews were conducted in a
private setting and women were guaranteed anonymity, it is
possible that participants still feared disclosing personally or
socially sensitive information. This may also have resulted
in misclassification that biased the results toward finding no
association between certain risk behaviors. This study was
limited by a small sample size and a low prevalence of HSV-
2 in the study population limiting the power of the study
to detect associations between personal characteristics and
HSV-2. Associations found in other studies between older
age and alcohol consumption and increased risk for HSV-2
infection were not found to be statistically significant in this
study. It is possible that with a larger sample size, associations
would be found between additional factors and increased risk
of HSV-2 infection.
This study provides needed information regarding the
prevalence of HSV-2 among rural pregnant women in India
and will serve as an important baseline measurement as
investigators continue tomonitor rates of HSV-2 in the future
in rural India.
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